Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2023-03-17 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Lupin Digital Health Unveils Results of India's First Digital Therapeutics Study with ACS Patients.
Regulatory Filings Classification · 95% confidence The document is a press release dated March 17, 2023, from Lupin Limited, disclosing results of a digital therapeutics study with ACS patients. It is addressed to stock exchanges under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, which pertains to material events or information. The content focuses on announcing study results and company information, not on financial results or detailed financial statements. It is not an earnings release, annual report, or interim report. The document is a disclosure announcement of a material event (study results) rather than a detailed investor presentation or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length (7173 characters) and content confirm it is not a brief report publication announcement or a certification. Hence, the classification is RNS with high confidence.
2023-03-17 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 95% confidence The document text is extremely short (569 characters) and consists solely of a digital signature block with no substantive content related to financial performance, management changes, or any report. There is no indication of any report, announcement, or filing type. Given the lack of content and the nature of the text, it does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2023-03-17 English
Intimation in respect of allotment of 24914 shares under ESOP.
Regulatory Filings Classification · 100% confidence The document text is extremely short (515 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report, meeting, financial data, or regulatory information. Given the lack of content and the nature of the text, it does not fit into any specific filing category. According to the fallback rule, such documents are best classified as Regulatory Filings (RNS).
2023-03-17 English
Lupin Bioresearch Centre Completes U.S. FDA Inspection with No Observations.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of a U.S. FDA inspection of Lupin Limited's Bioresearch Centre with no observations. It is addressed to stock exchanges as a disclosure pursuant to SEBI Listing Regulations. The content is a regulatory announcement about an inspection result, not a financial report, earnings release, or management discussion. The document length is under 5,000 characters and it serves as a disclosure announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-13 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of a U.S. FDA inspection of Lupin Limited's Bioresearch Centre with no observations. It is addressed to stock exchanges as a disclosure pursuant to SEBI Listing Regulations. The content is a regulatory announcement about an inspection outcome, not a financial report, management discussion, or detailed filing. The document length is short (3937 characters) and it serves as a disclosure rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-13 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of a U.S. FDA inspection of Lupin Limited's manufacturing facility with no observations. It is addressed to stock exchanges and references a regulatory disclosure under SEBI Listing Regulations. The content is an announcement of an event (inspection completion) rather than a detailed financial report, management discussion, or regulatory filing. The document length is 4227 characters, which is relatively short and consistent with a press release or regulatory announcement. There is no financial data, no voting results, no management changes, no earnings information, or other report content. Therefore, the document best fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2023-03-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.